CNCR Holdings — Loncar Cancer Immunotherapy ETF
All 76 reported holdings of Loncar Cancer Immunotherapy ETF (CNCR) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Recursion Pharmaceuticals Inc | 4.01% | $358.28K |
| Precigen Inc | 3.05% | $272.33K |
| Compass Therapeutics Inc | 2.99% | $266.91K |
| Genelux Corp | 2.90% | $259.01K |
| SpringWorks Therapeutics Inc | 2.86% | $255.65K |
| Exelixis Inc | 2.48% | $221.69K |
| Ginkgo Bioworks Holdings Inc | 2.33% | $208.17K |
| Replimune Group Inc | 2.14% | $190.80K |
| Bristol-Myers Squibb Co | 2.10% | $187.74K |
| Schrodinger Inc/United States | 1.98% | $176.81K |
| Blueprint Medicines Corp | 1.97% | $176.14K |
| Zymeworks Inc | 1.89% | $168.59K |
| Vor BioPharma Inc | 1.88% | $168.29K |
| HUTCHMED China Ltd | 1.76% | $156.73K |
| Innate Pharma SA | 1.73% | $154.11K |
| Monte Rosa Therapeutics Inc | 1.73% | $154.03K |
| ImmunityBio Inc | 1.66% | $148.37K |
| Merus NV | 1.65% | $147.67K |
| Enliven Therapeutics Inc | 1.64% | $146.50K |
| BioNTech SE | 1.61% | $143.97K |
| Revolution Medicines Inc | 1.61% | $143.98K |
| Immunocore Holdings PLC | 1.57% | $140.09K |
| Syndax Pharmaceuticals Inc | 1.51% | $135.25K |
| Genmab A/S | 1.50% | $134.29K |
| Arcellx Inc | 1.48% | $132.56K |
| Merck & Co Inc | 1.38% | $123.15K |
| Inhibrx Biosciences Inc | 1.34% | $119.65K |
| Aura Biosciences Inc | 1.32% | $118.24K |
| Xencor Inc | 1.28% | $114.31K |
| MacroGenics Inc | 1.26% | $112.88K |
| Allogene Therapeutics Inc | 1.25% | $111.20K |
| Arvinas Inc | 1.24% | $110.78K |
| Summit Therapeutics Inc | 1.24% | $110.48K |
| Karyopharm Therapeutics Inc | 1.22% | $108.98K |
| Legend Biotech Corp | 1.20% | $107.45K |
| Nuvalent Inc | 1.18% | $105.27K |
| Day One Biopharmaceuticals Inc | 1.17% | $104.62K |
| Janux Therapeutics Inc | 1.16% | $103.77K |
| Kymera Therapeutics Inc | 1.14% | $101.79K |
| Acrivon Therapeutics Inc | 1.14% | $101.55K |
| Arcus Biosciences Inc | 1.14% | $101.42K |
| Nuvation Bio Inc | 1.13% | $100.99K |
| Regeneron Pharmaceuticals Inc | 1.07% | $95.73K |
| Nurix Therapeutics Inc | 1.07% | $95.59K |
| RAPT Therapeutics Inc | 1.07% | $95.44K |
| iTeos Therapeutics Inc | 1.06% | $94.44K |
| Adicet Bio Inc | 1.06% | $94.31K |
| Tyra Biosciences Inc | 1.02% | $91.47K |
| Caribou Biosciences Inc | 1.02% | $90.71K |
| Immuneering Corp | 1.01% | $90.48K |
| Lyell Immunopharma Inc | 1.01% | $90.22K |
| Zentalis Pharmaceuticals Inc | 0.99% | $88.53K |
| Ideaya Biosciences Inc | 0.98% | $87.92K |
| 2seventy bio Inc | 0.97% | $86.38K |
| Foghorn Therapeutics Inc | 0.92% | $82.44K |
| Cullinan Therapeutics Inc | 0.88% | $78.92K |
| Apollomics Inc | 0.87% | $78.11K |
| Erasca Inc | 0.86% | $76.46K |
| Agenus Inc | 0.83% | $73.78K |
| Bicycle Therapeutics PLC | 0.77% | $69.15K |
| Autolus Therapeutics PLC | 0.76% | $68.07K |
| Iovance Biotherapeutics Inc | 0.76% | $67.95K |
| Sutro Biopharma Inc | 0.76% | $67.63K |
| Y-mAbs Therapeutics Inc | 0.75% | $67.26K |
| Relay Therapeutics Inc | 0.74% | $66.18K |
| First American Government Obli | 0.71% | $63.80K |
| Geron Corp | 0.71% | $63.39K |
| Kura Oncology Inc | 0.65% | $58.15K |
| Biomea Fusion Inc | 0.64% | $57.00K |
| Repare Therapeutics Inc | 0.63% | $55.94K |
| Immatics NV | 0.61% | $54.15K |
| Prelude Therapeutics Inc | 0.51% | $45.94K |
| Fate Therapeutics Inc | 0.50% | $44.51K |
| Mersana Therapeutics Inc | 0.47% | $41.81K |
| Tango Therapeutics Inc | 0.38% | $33.90K |
| IGM Biosciences Inc | 0.15% | $13.51K |
CNCR overview: performance, fees, allocation and SEC filings